article thumbnail

Diabetes drugs associated with fewer adverse cardiac events in older veterans

Medical Xpress

GLP1 receptor agonists—a class of diabetes medications—are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

article thumbnail

Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile

Physician's Weekly

WEDNESDAY, June 25, 2025 (HealthDay News) — Fecal microbiota transplantation (FMT) could be considered as first-line therapy for primary Clostridioides difficile infection (CDI), according to a study published online June 17 in the Annals of Internal Medicine. percent of 51 patients receiving FMT versus 61.2 Additional C.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is your telehealth setup up to snuff? 7 quick checkpoints for practices

Physician's Practice

7 quick checkpoints for practices June 26, 2025 By Keith A. Reynolds Fact checked by Chris Mazzolini Blog Article Telehealth has evolved into a vital service channel, yet many practices struggle with inadequate setups.

article thumbnail

Practice tip of the week: Improving the patient experience

Physician's Practice

Reynolds Feature Article Your weekly dose of wisdom from the Physicians Practice experts. lightbulb doodle © Matias - stock.adobe.com With all the useful information available on Physicians Practice, it is easy to become overwhelmed.

article thumbnail

Wakefulness-promoting agents effective for excessive daytime sleepiness but patients may discontinue due to side effects

Medical Xpress

A systematic review and analysis of 14 trials found that solriamfetol, armodafinil–modafinil, and pitolisant reduce excessive daytime sleepiness (ESA) for patients with obstructive sleep apnea (OSA) already using conventional therapy. The review is published in Annals of Internal Medicine.

article thumbnail

Tech upgrade success: 6 rules every practice should follow

Physician's Practice

Reynolds Fact checked by Chris Mazzolini Blog Article Navigating the health tech landscape requires strategic diligence to avoid hidden costs and ensure seamless integration in medical practices.

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure.